622 studies found for:    Open Studies | "Infant, Newborn, Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Standardized Treatment of Pulmonary Exacerbations II
Condition: Pulmonary Cystic Fibrosis
Intervention: Drug: Standard of care IV antibiotic(s)
22 Recruiting Infant-parent Skin-to-skin Contact During Screening for Retinopathy
Condition: Retinopathy of Prematurity
Interventions: Behavioral: skin-to-skin contact;   Device: incubator;   Drug: Sucrose
23 Recruiting Evaluation Of The Pan-microbiome and Host Immune Response in CF
Condition: Cystic Fibrosis (CF)
Intervention: Procedure: Two-Bronchoscope Technique
24 Recruiting Muscle Accrual and Function in Cystic Fibrosis-Impact of Glucose Intolerance
Condition: Cystic Fibrosis
Intervention:
25 Not yet recruiting Efficacy Study of the Draeger Jaundice Meter (JM-105) in Neonates of ≥ 24 Weeks of Gestational Age
Conditions: Hyperbilirubinemia;   Neonatal Jaundice
Intervention: Device: JM-105
26 Not yet recruiting Efficacy and Safety of Goat Lung Surfactant for the Treatment of Respiratory Distress Syndrome in Preterm Neonates
Condition: Respiratory Distress Syndrome
Interventions: Drug: Cadisurf;   Drug: Survanta
27 Recruiting nHFOV vs nCPAP: Effects on Gas Exchange for the Treatment of Neonates Recovering From RDS
Conditions: Respiratory Distress Syndrome;   Preterm Birth
Intervention: Device: Medin-cno
28 Not yet recruiting A Study in Preterm Neonates With RDS to Compare CUROSURF® Administration Through LISA and Conventional Administration
Condition: Respiratory Distress Syndrome, Newborn
Interventions: Drug: LISA combination product (Curosurf+catheter CHF6440);   Drug: Curosurf through conventional administration (endotracheal tube)
29 Not yet recruiting Effect of Acid Blockade on Microbiota and Inflammation in Cystic Fibrosis (CF)
Condition: Cystic Fibrosis
Intervention: Drug: PPI treatment
30 Recruiting Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Drug: FDL169
31 Not yet recruiting Aerosolized Albuterol Use in Severe BPD
Condition: Severe Bronchopulmonary Dysplasia
Interventions: Drug: Albuterol Sulfate;   Drug: Sterile Saline
32 Not yet recruiting Risk Factors and Prediction Score of ARDS After Cardiac Surgery
Conditions: Respiratory Distress Syndrome, Adult;   Thoracic Surgery;   Risk Factors
Intervention: Other: no intervention
33 Not yet recruiting Effect of GS-5745 on FEV1 in Adults With Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Drug: GS-5745;   Drug: Placebo
34 Not yet recruiting Registry Study on Cystic Fibrosis in Chinese Children
Condition: Cystic Fibrosis
Intervention:
35 Not yet recruiting Exercise and Oscillatory Positive Expiratory Pressure Therapy in Cystic Fibrosis
Condition: Cystic Fibrosis
Interventions: Device: Flutter®;   Device: No Flutter®
36 Not yet recruiting Absorption and Safety With Sustained Use of Relizorb Evaluation (ASSURE) Study
Conditions: Exocrine Pancreatic Insufficiency;   Cystic Fibrosis
Interventions: Device: Relizorb;   Other: Impact Peptide 1.5
37 Not yet recruiting Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders
Conditions: Lung Transplant;   Lung Resection;   Lung Cancer;   Asthma;   Cystic Fibrosis;   Chronic Obstructive Pulmonary Disease;   Emphysema;   Mesothelioma;   Asbestosis;   Pulmonary Embolism;   Interstitial Lung Disease;   Pulmonary Fibrosis;   Bronchiectasis;   Seasonal Allergies;   Cold Virus;   Lung Infection;   Pulmonary Hypertension;   Pulmonary Dysplasia;   Obstructive Sleep Apnea
Interventions: Drug: HP 3He;   Drug: HP 129Xe;   Drug: PFP;   Drug: SF6;   Device: 129Xe Small and Large Human Lung Coil;   Device: 3He Human Lung Coil;   Device: PFP and SF6 Human Lung Coil
38 Recruiting A Study to Evaluate Efficacy and Safety of Ivacaftor in Subjects With Cystic Fibrosis Aged 3 Through 5 Years Who Have a Specified CFTR Gating Mutation
Condition: Cystic Fibrosis
Interventions: Drug: ivacaftor;   Drug: Placebo
39 Recruiting Xenon-129 Lung Magnetic Resonance Imaging: Study of Healthy Volunteers and Participants With Pulmonary Disease
Conditions: Cystic Fibrosis;   Asthma
Interventions: Drug: Xenon-129;   Device: Magnetic Resonance Imaging;   Device: Lung Clearance Index
40 Not yet recruiting SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis
Conditions: Exocrine Pancreatic Insufficiency;   Cystic Fibrosis
Intervention: Drug: Liprotamase Powder for Oral Solution

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years